A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes
Public ClinicalTrials.gov record NCT03311724. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Double-Blind, Placebo-Controlled, 3-Month Trial of LY3298176 Versus Placebo in Patients With Type 2 Diabetes Mellitus
Study identification
- NCT ID
- NCT03311724
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Eli Lilly and Company
- Industry
- Enrollment
- 111 participants
Conditions and interventions
Conditions
Interventions
- Tirzepatide Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 18, 2017
- Primary completion
- Apr 23, 2018
- Completion
- Apr 23, 2018
- Last update posted
- May 18, 2021
2017 – 2018
United States locations
- U.S. sites
- 13
- U.S. states
- 9
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Valley Research | Fresno | California | 93720 | — |
| National Research Institute | Los Angeles | California | 90057 | — |
| Catalina Research Institute, LLC | Montclair | California | 91763 | — |
| University Clinical Investigators, Inc. | Tustin | California | 92780 | — |
| Chase Medical Research, LLC | Waterbury | Connecticut | 06708 | — |
| Suncoast Research Group, LLC | Miami | Florida | 33135 | — |
| Solaris Clinical Research | Meridian | Idaho | 83646 | — |
| Cotton O'Neil Diabetes and Endocrinology Center | Topeka | Kansas | 66606 | — |
| Clinical Research Professionals | St Louis | Missouri | 63141 | — |
| Aventiv Research | Columbus | Ohio | 43213 | — |
| New Phase Research & Development | Knoxville | Tennessee | 37909 | — |
| Dallas Diabetes Endocrine Center | Dallas | Texas | 75230 | — |
| Consano Clinical Research | Shavano Park | Texas | 78231 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03311724, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 18, 2021 · Synced Jun 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03311724 live on ClinicalTrials.gov.